Regarding oxidative stress markers, MetS was associated with an upregulation of the prooxidant enzyme NOX-1 that was prevented by BPL1® HT, administered alone or in combination with CTE (p < 0.05 for both). Here, NOX1 is linked to metabolic syndrome.